Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Наслов

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Идентификатор

/unibl/sci/idNaucniRad:16548

Тип

Датум

Библиографски цитат

B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015

Референца

Почетна страница

125

Крајња страница

135

Је дио

Листа аутора

Веза

Position: 696 (58 views)